The optimal management of polycythaemia vera.
Spivak
Jerry L
JL
Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jlspivak@mail.jhmi.edu
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D007964:Leukocytosis / Q000150:complications / Q000628:therapy; D008297:Male; D011087:Polycythemia Vera / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy; D055728:Primary Myelofibrosis / Q000628:therapy; D011537:Pruritus / Q000150:complications / Q000628:therapy; D013163:Splenomegaly / Q000150:complications / Q000628:therapy; D013276:Stomach Ulcer / Q000150:complications / Q000628:therapy; D013922:Thrombocytosis / Q000150:complications / Q000628:therapy
D020533:Angiogenesis Inhibitors; D016898:Interferon-alpha